<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02320643</url>
  </required_header>
  <id_info>
    <org_study_id>POP-SERATOM PA</org_study_id>
    <nct_id>NCT02320643</nct_id>
  </id_info>
  <brief_title>A Pilot Study to Investigate the Efficacy of Partially Absorbable Mesh in Patients With Pelvic Organ Prolapsed</brief_title>
  <official_title>A Prospective Pilot Study to Investigate the Efficacy of Partially Absorbable Mesh(Seratom PA®) in Patients With Pelvic Organ Prolapsed</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samyang Biopharmaceuticals Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samyang Biopharmaceuticals Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy, recurrence, postoperative
      complications of partially absorbable mesh(Seratom®PA) in patients with pelvic organ
      prolapse.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with pelvic organ prolapse are administrated partially absorbable mesh(Seratom®PA).
      It is performed pelvic organ prolapse quantification(POP-Q) examination, quality of life(QOL)
      questionnaire complications at postop 2week, 12week, 24week.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2014</start_date>
  <completion_date type="Actual">April 2017</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pelvic Organ Prolapse Quantification(POP-Q) stage</measure>
    <time_frame>Change from baseline in Pelvic Organ Prolapse Quantification(POP-Q) stage at postop 2week, 12week, 24week</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Surgical revision rate</measure>
    <time_frame>For post op 6 months from baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>No of patients complications occurred</measure>
    <time_frame>For post op 6 months from baseline</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>Seratom® PA mesh</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Partially absorbable mesh</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Seratom® PA mesh</intervention_name>
    <description>Partially absorbable mesh</description>
    <arm_group_label>Seratom® PA mesh</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Woman who aged 41 years or older

          2. Subjects who have symptomatic pelvic organ prolapse quantification(POP-Q) stage II &amp;
             cystocele or higher requiring surgical repair

          3. Subjects who desires vaginal reconstructive surgery

          4. Subjects who have uterus &lt; 12 weeks size

          5. Subjects who are able to complete study questionnaires and assessment

          6. Subjects who are available for 6 months follow-up

        Exclusion Criteria:

          1. Subjects who have medical contractions, e.g. current urinary tract, vaginal or pelvic
             infection, history of pelvic irradiation, history of lower urinary tract malignancy,
             chronic steroid use, or a compromised immune system

          2. Subjects who have received anticoagulation therapy

          3. Subjects who are on current intermittent catheterization

          4. Subjects whose BMI is over 30kg/m2

          5. Subjects who have uncontrolled diabetes

          6. Subjects who are on any medication which could result in compromised immune response,
             such as immune modulators

          7. Subjects who are currently pregnant or intends to become pregnant during the study
             period or &lt;12 months post-partum

          8. Subjects who have received other laparoscopic or abdominal or pelvic surgery in the
             past 1 months

          9. Subjects who need for concomitant surgery requiring an abdominal incision

         10. Subjects who have had a prior prolapse implant procedure (i.e. IVS tunneler, Perigee,
             Apogee, graft augmented repair, etc)

               -  Note: previous traditional repairs are allowed.

         11. Subjects who have had radiation therapy to the pelvic area

         12. Subjects who have pelvic cancer or have had pelvic cancer within the past 12 months or
             have had on cytostatic medication within the past 12 months

         13. Subjects who have a shortened vagina or other known Mullerian anomaly (e.g. uterine
             didelphys.)

         14. Subjects who have a known neurologic or medical condition affecting bladder function
             (e.g. Multiple Sclerosis, spinal cord injury)

         15. Subjects who have a known hypersensitivity to the graft material(s)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>41 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kwon Sang Hoon, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Keimyung University Dongsan Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samyang Biopharmaceuticals</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2014</study_first_submitted>
  <study_first_submitted_qc>December 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2014</study_first_posted>
  <last_update_submitted>April 27, 2017</last_update_submitted>
  <last_update_submitted_qc>April 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Partially absorbable mesh</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

